Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02395588 · ClinicalTrials.gov registry record
Improving Heart Failure Outcomes Rural
A clinical trial, sponsored by University of Maryland, Baltimore.
- Completed
- Registry status
- 26
- Enrollment target
NCT02395588: Completed study, sponsored by University of Maryland, Baltimore.
NCT02395588 is a clinical trial that has completed, run by University of Maryland, Baltimore. The registered enrollment target is 26 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02395588 has completed, sponsored by University of Maryland, Baltimore.
- COMPLETED
- Registry status
- 26 participants
- Enrollment target
Study Summary
This study will test if standardized care helps patients feel better, if it can be implemented in rural hospitals, and find out which healthcare processes and outcomes are most important to heart failure patients.
Primary Outcome
Self-care of Heart Failure Index
Interventions
- OTHER Guideline based care
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 26 participants |
| Start Date | 2014-04 |
| Est. Completion | 2015-06 |
What the finished NCT02395588 record still lists
NCT02395588 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 26 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Guideline based care is the first listed.
NCT02395588 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02395588 about?
NCT02395588 is a clinical study titled "Improving Heart Failure Outcomes Rural". This study will test if standardized care helps patients feel better, if it can be implemented in rural hospitals, and find out which healthcare processes and outcomes are most important to heart failure patients.
What is the current status of trial NCT02395588?
This trial is currently completed. The enrollment target is 26 participants. The study started on 2014-04. Estimated completion is 2015-06.
What interventions are being tested in trial NCT02395588?
The interventions under investigation include: Guideline based care (OTHER).
Who is sponsoring clinical trial NCT02395588?
This trial is sponsored by University of Maryland, Baltimore, which has 560 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02646475 · 26 participants · Phase 1
Metabolic Effects of Angiotensin-(1-7)
- NCT03603223 · 26 participants · Phase 2
Pembrolizumab in Treating Participants With Leukoplakia
- NCT04063592 · 26 participants · NA
AMI Construction in Lower Extremity Residual Limbs
- NCT04906460 · 26 participants · Phase 1
Open-label Study of WVE-N531 in Patients With Duchenne Muscular Dystrophy (FORWARD-53)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia